Ascension Saint Thomas and Nashville Yards Announce Founding Partnership

Leading Health System Becomes Official Healthcare Partner of Nashville Yards. Plans Include Future Launch of an On-Site Clinic at the 18-Acre Development

Ascension Saint Thomas has entered into a strategic agreement with Southwest Value Partners and AEG, joint venture partners and co-developers of the Nashville Yards entertainment district and music venue, to become a Founding Partner of the 18-acre Nashville Yards as well as the exclusive naming rights partner for the project’s open plaza and green space, to be known as Ascension Saint Thomas Landing.

As part of the multi-year agreement, brokered by AEG Global Partnerships, Ascension Saint Thomas will serve as the development’s official healthcare partner.

As a Founding Partner, a premium and category exclusive designation, Ascension Saint Thomas will be prominently featured at Nashville Yards with custom brand integration across the development. This will include year-round exposure within the development’s signage network and messaging within Nashville Yards’ mobile app and digital channels.

The agreement will also expand the health system’s footprint into downtown Nashville with a forthcoming on-site clinic within the development’s retail footprint. Ascension Saint Thomas and Nashville Yards will work collaboratively on new initiatives that promote positive health outcomes, encourage overall healthy living, and increase access to quality healthcare to meet the needs of the rapidly growing community.

“Ascension Saint Thomas has a long-standing commitment to community partnerships with the goal of making innovative and personalized care accessible to all Middle Tennesseans,” said Tim Adams, president and CEO, Ascension Saint Thomas. “We are excited to bring best-in-class resources to those who live and work in downtown Nashville through this partnership.”

“We are thrilled to partner with Ascension Saint Thomas, with whom we so completely share a commitment to health and community,” said Cary Mack, managing partner, Southwest Value Partners. “We look forward to together elevating the quality of life for residents and visitors alike at Nashville Yards.”

Ascension Saint Thomas Landing is a major cornerstone of the partnership and will provide the leading health system with a significant opportunity to introduce millions of people to various health and wellness events. With a beautifully landscaped open area for guests to enjoy, the Landing will span the west side of the project from Broadway to Church Street and will serve as a welcoming “front door” to Nashville Yards.

Ascension Saint Thomas will engage guests through various entertainment touch points, while strengthening its ties to Nashville’s vibrant urban core. These will include custom on-site activations and impactful community events that benefit the people and businesses of Nashville, such as curated concerts, speaker series and unique event programming at the development’s 4,000-capacity, state-of-the-art live music venue.

“Ascension Saint Thomas has been a highly respected leader in the Nashville community for more than a century and we could not be prouder to welcome them to the Nashville Yards family of partners,” said Scott Emery, senior director, AEG Global Partnerships. “At the center of this agreement lies a mutual commitment to community. Together, we look forward to helping people live their healthiest lives possible, bringing new forms of engagement and healthcare to our guests at Nashville Yards, and working hand in hand to give back and make a positive impact for generations to come.”

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy